Northfield Laboratories at centre of US row on informed consent waiver
This article was originally published in Clinica
Executive Summary
The chairman of the US Senate finance committee has launched an investigation into the FDA's decision to sanction tests of a blood substitute on trauma patients without their "meaningful" informed consent.